Increased mRNA expression of phospholipase D (PLD) isozymes during granulocytic differentiation of HL60 cells.
In response to dibutyryl cyclic AMP (dbcAMP) and all-trans retinoic acid (ATRA), HL60 cells differentiate into granulocyte-like cells. Membrane-associated phospholipase D (PLD) activity in response to guanosine 5'-O-(3-thiotriphosphate) (GTP gamma S) or phorbol myristate acetate (PMA) was upregulated by these treatments. Reverse transcriptase-polymerase chain reaction (RT-PCR) analyses revealed that both hPLD1a and hPLD1b mRNAs were expressed in HL60 cells and that their expression levels increased during differentiation. hPLD2 mRNA levels rose dramatically during differentiation. These results suggest that the PLD genes undergo changes in transcriptional regulation during granulocytic differentiation of HL60 cells.
Nakashima
S
S
Department of Biochemistry, Gifu University School of Medicine, Japan. bio@cc.gifu-u.ac.jp
Ohguchi
K
K
Frohman
M A
MA
Nozawa
Y
Y
D003994:Bucladesine / Q000494:pharmacology; D002454:Cell Differentiation / Q000187:drug effects; D015971:Gene Expression Regulation, Enzymologic / Q000187:drug effects; D006098:Granulocytes / Q000166:cytology* / Q000201:enzymology; D018922:HL-60 Cells / Q000166:cytology* / Q000201:enzymology; D006801:Humans; D007527:Isoenzymes / Q000096:biosynthesis*; D007700:Kinetics; D010739:Phospholipase D / Q000096:biosynthesis*; D016133:Polymerase Chain Reaction; D012333:RNA, Messenger / Q000096:biosynthesis; D013755:Tetradecanoylphorbol Acetate / Q000494:pharmacology; D013997:Time Factors; D014158:Transcription, Genetic / Q000187:drug effects; D014212:Tretinoin / Q000494:pharmacology
D007527:Isoenzymes; D012333:RNA, Messenger; D014212:Tretinoin; D003994:Bucladesine; D010739:Phospholipase D; D013755:Tetradecanoylphorbol Acetate